Guantao Advised CASI Pharmaceuticals, Inc. (Nasdaq: CASI) on its At-the-Market Offering-亚洲最大赌博网站

Guantao Advised CASI Pharmaceuticals, Inc. (Nasdaq: CASI) on its At-the-Market Offering

2019-07-23

HOME > Guantao News > Deals > Guantao Advised CASI Pharmaceuticals, Inc. (Nasdaq: CASI) on its At-the-Market Offering

Guantao Advised CASI Pharmaceuticals, Inc. (Nasdaq: CASI) on its At-the-Market Offering

Eastern Time (US & Canada) July 19, 2019, CASI Pharmaceuticals, Inc. (Nasdaq: CASI) entered into an Open Market Sale AgreementSM with Jefferies LLC. Pursuant to the terms of the Sales Agreement, CASI may elect to sell from time to time, at its option, up to $30 million shares of its common stock through Jefferies LLC, as sales agent by any method permitted that is deemed an 'at the market offering' as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended.

Guantao team led by Hong Kong office managing partner Grace Pengpeng YAN and Yan RONG acted as the legal adviser to Jefferies LLC as to the laws of the People’s Republic of China.

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and accelerating the launch of innovative therapeutics and high quality pharmaceutical products in China, U.S., and throughout the world.

2025·09·18

Guantao Advises Huayan Cheng on Its Increased Acquisition of Shares in Huacheng Industrial Control Co., Ltd. (Stock Code: 873553)

2025·08·08

Guantao Deals │Guantao Advises Tosso, an AI-Powered Robotic Sanding and Polishing Company, on Its Series A Financing

2025·07·30

Guantao Deals | Guantao to assist PetroChina Kunlun Capital and other investors in the capital increase of China Fusion Energy Co., Ltd.

2025·07·29

Guantao Deals | Guantao Advises CNPC Taihu Investment on Its Capital Increase in State Grid Xinyuan Holdings